ZA885517B - Gepirone for alleviation of panic disorders - Google Patents

Gepirone for alleviation of panic disorders

Info

Publication number
ZA885517B
ZA885517B ZA885517A ZA885517A ZA885517B ZA 885517 B ZA885517 B ZA 885517B ZA 885517 A ZA885517 A ZA 885517A ZA 885517 A ZA885517 A ZA 885517A ZA 885517 B ZA885517 B ZA 885517B
Authority
ZA
South Africa
Prior art keywords
gepirone
alleviation
panic disorders
panic
disorders
Prior art date
Application number
ZA885517A
Other languages
English (en)
Inventor
Neil Kurtz
Kurtz Neil
Roger E Newton
E Newton Roger
Davis L Temple
L Temple Davis
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZA885517B publication Critical patent/ZA885517B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA885517A 1987-07-29 1988-07-28 Gepirone for alleviation of panic disorders ZA885517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/079,190 US4782060A (en) 1987-07-29 1987-07-29 Gepirone for alleviation of panic disorders

Publications (1)

Publication Number Publication Date
ZA885517B true ZA885517B (en) 1989-03-29

Family

ID=22148994

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885517A ZA885517B (en) 1987-07-29 1988-07-28 Gepirone for alleviation of panic disorders

Country Status (10)

Country Link
US (1) US4782060A (xx)
EP (1) EP0301239B1 (xx)
JP (1) JPH0692303B2 (xx)
KR (1) KR960014873B1 (xx)
AT (1) ATE112167T1 (xx)
AU (1) AU601056B2 (xx)
CA (1) CA1312826C (xx)
DE (1) DE3851669T2 (xx)
ES (1) ES2059442T3 (xx)
ZA (1) ZA885517B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4634703A (en) * 1985-10-25 1987-01-06 Bristol-Myers Company Method for alleviation of panic disorders
US4771053A (en) * 1987-03-02 1988-09-13 Bristol-Myers Company Method for alleviation of primary depressive disorders
DE3727879A1 (de) * 1987-08-21 1989-03-02 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten

Also Published As

Publication number Publication date
EP0301239A3 (en) 1990-10-10
ES2059442T3 (es) 1994-11-16
KR890001558A (ko) 1989-03-27
JPS6442434A (en) 1989-02-14
CA1312826C (en) 1993-01-19
AU601056B2 (en) 1990-08-30
DE3851669T2 (de) 1995-02-02
AU1905088A (en) 1989-02-02
EP0301239B1 (en) 1994-09-28
DE3851669D1 (de) 1994-11-03
ATE112167T1 (de) 1994-10-15
US4782060A (en) 1988-11-01
EP0301239A2 (en) 1989-02-01
KR960014873B1 (ko) 1996-10-21
JPH0692303B2 (ja) 1994-11-16

Similar Documents

Publication Publication Date Title
GR3007393T3 (xx)
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
EP0715851A3 (en) Substituted phenylpyrimidine derivatives useful in the treatment or prevention of diseases of the central nervous system
MY103352A (en) Piperazinyl-heterocyclic compounds
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
AP8800106A0 (en) Substituted tetrarins chromans & related compounds in the treatment of asthma,arthritis etc.
EP0282818A3 (en) The use of gepirone for preparing a pharmaceutical composition for alleviation of primary depressive disorders
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
KR960003617B1 (en) Crystallized cephem-acid addition salts, and the preparation process thereof
IT8820935A0 (it) Procedimento per la preparazione di 1,2,5,6,9,10 esabromociclododecano.
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
ZA885517B (en) Gepirone for alleviation of panic disorders
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO166642C (no) Anaolgifremgangsmaate for fremstilling av terapeutisk aktive 3-aryl-5-alkylthio-4h-1,2,4-triazoler.
IT8546808A1 (it) Dispositivo per l'ammortizzazione delle barelle delle autolettighe in genere.
RU96119673A (ru) Способ лечения болевого синдрома
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
IT8723152A0 (it) Copoliazometini termotropici eprocedimento per la loro preparazione.
JPS6422876A (en) 8 alpha-acylaminoergoline, manufacture and medicine
Babich et al. Heat Treatment of Railroad Rails